scholarly article | Q13442814 |
P2093 | author name string | Young K Song | |
Yong J Lee | |||
Timothy R Billiar | |||
P2860 | cites work | Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma | Q24308888 |
Expression of galectin-3 modulates T-cell growth and apoptosis | Q24309392 | ||
Mechanisms involved in the pro- and anti-apoptotic role of NO in human leukemia | Q34037781 | ||
Identification of galectin-3 as a factor in pre-mRNA splicing | Q34706659 | ||
Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. | Q35753328 | ||
Human T lymphotropic virus-I infection of human T lymphocytes induces expression of the beta-galactoside-binding lectin, galectin-3 | Q35773680 | ||
Galectin-3, a beta-galactoside-binding animal lectin, is a marker of anaplastic large-cell lymphoma. | Q35773778 | ||
Galectin-3 induces endothelial cell morphogenesis and angiogenesis | Q35809815 | ||
Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells | Q36356339 | ||
Identification of human melanoma cellular and secreted ligands for galectin-3. | Q36733533 | ||
Down-regulation of galectin-3 suppresses tumorigenicity of human breast carcinoma cells. | Q38302115 | ||
S-type mammalian lectins in allergic inflammation | Q38315519 | ||
Galectin-3 stimulates cell proliferation | Q38330513 | ||
Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death | Q38336667 | ||
Galectin-3 mediates genistein-induced G(2)/M arrest and inhibits apoptosis | Q38525760 | ||
Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells | Q40933105 | ||
Reactive nitrogen and oxygen radicals formed during hepatic ischemia-reperfusion kill weakly metastatic colorectal cancer cells | Q40959049 | ||
Metastasis of human colon cancer is altered by modifying expression of the beta-galactoside-binding protein galectin 3. | Q41022285 | ||
Role of nitric oxide and superoxide anion in elimination of low metastatic human colorectal carcinomas by unstimulated hepatic sinusoidal endothelial cells | Q41051970 | ||
The pathophysiological role of peroxynitrite in shock, inflammation, and ischemia-reperfusion injury. | Q41151395 | ||
Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver | Q41179928 | ||
Galectins: a family of animal lectins that decipher glycocodes | Q41201922 | ||
Implantation of human colorectal carcinoma cells in the liver studied by in vivo fluorescence videomicroscopy | Q41225378 | ||
Induction of tumorigenicity by galectin-3 in a nontumorigenic human breast-carcinoma cell-line. | Q41273337 | ||
Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications | Q41786603 | ||
Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms | Q42546244 | ||
Transformation-related changes in the expression of endogenous cell lectins | Q42808491 | ||
The roles of iNOS in liver ischemia-reperfusion injury | Q43792647 | ||
Galectins: a family of animal beta-galactoside-binding lectins | Q48084852 | ||
Reoxygenation injury in rat hepatocytes: mediation by O2/H2O2 liberated by sources other than xanthine oxidase. | Q52448369 | ||
BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. | Q52514947 | ||
Expression of an endogenous galactose-binding lectin correlates with neoplastic progression in the colon. | Q53463132 | ||
Evidence for the role of 34-kDa galactoside-binding lectin in transformation and metastasis. | Q53503954 | ||
Galectin-3 overexpression protects from cell damage and death by influencing mitochondrial homeostasis. | Q54050949 | ||
Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties | Q63413190 | ||
O2-. release by activated Kupffer cells upon hypoxia-reoxygenation | Q68258871 | ||
Decreased expression of galectin-3 is associated with progression of human breast cancer | Q71218237 | ||
Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase | Q71694221 | ||
Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-alpha-induced apoptosis by inducing heat shock protein 70 expression | Q71973760 | ||
Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin | Q72538898 | ||
Induction of nitric oxide production by natural killer cells: its role in tumor cell death | Q73114746 | ||
B16 melanoma cell arrest in the mouse liver induces nitric oxide release and sinusoidal cytotoxicity: a natural hepatic defense against metastasis | Q73144217 | ||
Cellular non-heme iron content is a determinant of nitric oxide-mediated apoptosis, necrosis, and caspase inhibition | Q73643152 | ||
Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family | Q73931768 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | breast cancer | Q128581 |
cancer metastasis | Q120912394 | ||
P304 | page(s) | 1069-1075 | |
P577 | publication date | 2002-03-01 | |
P1433 | published in | The American Journal of Pathology | Q4744259 |
P1476 | title | Role of galectin-3 in breast cancer metastasis: involvement of nitric oxide | |
P478 | volume | 160 |
Q28242012 | 90K (Mac-2 BP) and galectins in tumor progression and metastasis |
Q35689627 | A Mutation in the Carbohydrate Recognition Domain Drives a Phenotypic Switch in the Role of Galectin-7 in Prostate Cancer |
Q35096060 | An anti-apoptotic role for galectin-3 in diffuse large B-cell lymphomas |
Q33966490 | Analysis and prediction of cancerlectins using evolutionary and domain information. |
Q91283843 | Bioengineered tumor microenvironments with naked mole rats high-molecular-weight hyaluronan induces apoptosis in breast cancer cells |
Q80603048 | Diagnostic value of galectin-3 as a marker for malignancy in follicular patterned thyroid lesions |
Q34257806 | Effect of hyperthermia in combination with TRAIL on the JNK-Bim signal transduction pathway and growth of xenograft tumors |
Q38819632 | Expression of Sialyl Lewis a, Sialyl Lewis x, Lewis y, Gal-3, Gal-7, STMN1 and p16 in cervical dysplasia |
Q34208599 | Expression of liver-intestine cadherin and its possible interaction with galectin-3 in ductal adenocarcinoma of the pancreas |
Q42451393 | Galectin 3 and its binding protein in rheumatoid arthritis. |
Q35646658 | Galectin-3 and metastasis |
Q39053837 | Galectin-3 coats the membrane of breast cells and makes a signature of tumours |
Q53319954 | Galectin-3 expression in tumor progression and metastasis of papillary thyroid carcinoma. |
Q82213466 | Galectin-3 in urine of cancer patients: stage and tissue specificity |
Q35392528 | Galectin-3 up-regulation in hypoxic and nutrient deprived microenvironments promotes cell survival |
Q34626339 | Galectin-3: a potential target for cancer prevention. |
Q46542587 | Galectins as markers of aggressiveness of mouse mammary carcinoma: towards a lectin target therapy of human breast cancer |
Q34381235 | Galectins as modulators of tumour progression |
Q49149324 | Identification of galectin-3 and mucin-type O-glycans in breast cancer and its metastasis to brain |
Q42002845 | Immunolocalization of galectin-3 in mouse testicular tissue. |
Q36331168 | Inducible nitric oxide synthase contributes to immune dysfunction following trauma |
Q40127914 | Inhibition of galectin-3 mediated cellular interactions by pectic polysaccharides from dietary sources |
Q39553661 | Modified apple polysaccharide prevents against tumorigenesis in a mouse model of colitis-associated colon cancer: role of galectin-3 and apoptosis in cancer prevention |
Q27022305 | Nitric oxide in cancer metastasis |
Q37971860 | Novel anti-cancer compounds for developing combinatorial therapies to target anoikis-resistant tumors |
Q24307907 | Nucling mediates apoptosis by inhibiting expression of galectin-3 through interference with nuclear factor kappaB signalling |
Q39994161 | Pancreatic stellate cells promote proliferation and invasiveness of human pancreatic cancer cells via galectin-3 |
Q48276901 | Physiologically induced changes in bound phenolics and antioxidants, DNA/cytoprotective potentials in pectic poly/oligosaccharides of tomato (Solanum lycopersicum). |
Q36357328 | Predicting cancerlectins by the optimal g-gap dipeptides. |
Q92669100 | Prognostic impact of interleukin-6 and C-reactive protein on patients with breast cancer |
Q34534423 | Proteomic comparison of mcf-7 tumoursphere and monolayer cultures |
Q37082092 | Quantitative Proteomics Analysis of VEGF-Responsive Endothelial Protein S-Nitrosylation Using Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC) and LC-MS/MS |
Q33917622 | Rad51 supports triple negative breast cancer metastasis |
Q37164578 | Regulation of prostate cancer progression by galectin-3 |
Q26797253 | Role of phytochemicals in colorectal cancer prevention |
Q39785502 | Silencing of galectin-3 changes the gene expression and augments the sensitivity of gastric cancer cells to chemotherapeutic agents |
Search more.